Melatonin Versus Placebo for Bipolar Disorder

Summary

The objective with this study is to conduct a 6-month RCT comparing effects of add-on melatonin versus add-on placebo on mood stabilisation and other critical patient outcomes in patients with BD and to test whether principal effects are antimanic, antidepressant and/or prophylactic against relapse

Timeline

Start

2026-05-08

Primary completion

2028-06

Completion

2028-06

Drugs

Indications